Male Contraceptive Initiative's funding opportunities seek to advance research and development of male contraception.
Discover a variety of grant and funding opportunities dedicated to supporting innovative research and development in male contraception. We aim to drive progress forward through offering financial support for projects that focus on non-hormonal, reversible male contraceptives. We also believe in supporting young researchers in the field to ensure future initiatives in male contraception continue. Find detailed information about our funding opportunities, links to announcements, and contact details on this page.
Current MCI Research Funding
Grants & Investments
MCI funds multiple awards that allow investigators to take defined, measurable steps forward in male contraceptive research and development. MCI's 2024 Grant cycle is currently closed (Please note that MCI utilizes ProposalCentral to manage our grants, and you will need to create a free profile on their website in order to submit your application). Please reach out to us with any questions about future grant opportunities here.
MCI funds multiple awards that allow investigators to take defined, measurable steps forward in male contraceptive research and development. MCI's 2024 Grant cycle is currently closed (Please note that MCI utilizes ProposalCentral to manage our grants, and you will need to create a free profile on their website in order to submit your application). Please reach out to us with any questions about future grant opportunities here.
-------------------------
MCI-BCM Sponsored Target Screening
This opportunity will facilitate the screening of validated male contraceptive targets for small-molecule inhibitors using the DNA-Encoded Chemistry Technology (DEC-Tec) core facilities available in the lab of Dr. Martin Matzuk and Center for Drug Discovery at Baylor College of Medicine (BCM). The purpose of this opportunity is to allow investigators with validated male contraceptive targets to utilize state-of-the-art screening facilities to identify “hit” molecules that bind to the target of interest.
We are now accepting applications for the MCI-BCM Sponsored Target Screening Award. Please see the application announcement for details, and reach out to us with any questions.
This opportunity will facilitate the screening of validated male contraceptive targets for small-molecule inhibitors using the DNA-Encoded Chemistry Technology (DEC-Tec) core facilities available in the lab of Dr. Martin Matzuk and Center for Drug Discovery at Baylor College of Medicine (BCM). The purpose of this opportunity is to allow investigators with validated male contraceptive targets to utilize state-of-the-art screening facilities to identify “hit” molecules that bind to the target of interest.
We are now accepting applications for the MCI-BCM Sponsored Target Screening Award. Please see the application announcement for details, and reach out to us with any questions.
-------------------------
For information about future grant opportunities please reach out to [email protected], and be sure to subscribe to our newsletter at the bottom of this page in order to be notified of the latest Male Contraceptive Initiative funding opportunities!
MCI's Trainee & Youth Funding Opportunities
Trainee Fellowships
Male Contraceptive Initiative supports a fellowship program for graduate students and postdoctoral trainees working with senior investigators in the field of male contraceptives. Our 2024 Fellowship cycle is currently closed. Please reach out to us at [email protected] with any questions.
Male Contraceptive Initiative supports a fellowship program for graduate students and postdoctoral trainees working with senior investigators in the field of male contraceptives. Our 2024 Fellowship cycle is currently closed. Please reach out to us at [email protected] with any questions.
-------------------------
Trainee Success Program
MCI supports the career development of graduate and postdoctoral trainees directly through our Success program. Applications are accepted on a rolling basis for any activity or need that advances the career of a trainee interested in the field of male contraception. Examples of eligible activities include travel grants, digital conferences, workshops, and other professional development opportunities. Applications are evaluated based on relevance of the proposed activity, applicant strength and available funds. Applicants are encouraged to contact [email protected] for questions regarding eligibility. Read what previous Trainee Success recipients say about the program here.
MCI supports the career development of graduate and postdoctoral trainees directly through our Success program. Applications are accepted on a rolling basis for any activity or need that advances the career of a trainee interested in the field of male contraception. Examples of eligible activities include travel grants, digital conferences, workshops, and other professional development opportunities. Applications are evaluated based on relevance of the proposed activity, applicant strength and available funds. Applicants are encouraged to contact [email protected] for questions regarding eligibility. Read what previous Trainee Success recipients say about the program here.
-------------------------
The Beverly Tucker Award
Beverly Tucker, MPH, MPIA, PMP, is a founding board member of Male Contraceptive Initiative and has an illustrious career in global health spanning decades, as well as continents. She is a champion for male contraception, and passionate about supporting scientists all over the world. The annual Tucker Award was established in 2020 to support professional development in the setting of international health. Male Contraceptive Initiative’s Beverly Tucker Award provides up to $5,000 to support a student or professional residing outside of the United States to travel internationally for the purposes of career development. We are currently accepting applications for the Tucker Award. Please see the application details for more information, or reach out to us with any questions at [email protected].
Beverly Tucker, MPH, MPIA, PMP, is a founding board member of Male Contraceptive Initiative and has an illustrious career in global health spanning decades, as well as continents. She is a champion for male contraception, and passionate about supporting scientists all over the world. The annual Tucker Award was established in 2020 to support professional development in the setting of international health. Male Contraceptive Initiative’s Beverly Tucker Award provides up to $5,000 to support a student or professional residing outside of the United States to travel internationally for the purposes of career development. We are currently accepting applications for the Tucker Award. Please see the application details for more information, or reach out to us with any questions at [email protected].
-------------------------
MCI's Youth Advisory Board Undergraduate Project Grant
MCI's Youth Advisory Board (YAB) is a group of young people (ages 16-28) providing their perspectives to our work and advocating for male contraception. This request for applications is for undergraduate students interested in working on projects related to new male contraception. Applications for the grant are now closed. Those interested in learning more are encouraged to contact [email protected] for questions regarding future opportunities.
MCI's Youth Advisory Board (YAB) is a group of young people (ages 16-28) providing their perspectives to our work and advocating for male contraception. This request for applications is for undergraduate students interested in working on projects related to new male contraception. Applications for the grant are now closed. Those interested in learning more are encouraged to contact [email protected] for questions regarding future opportunities.
External Funding Opportunities
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
This funding opportunity from NICHD provides investigators access to the Chemical Synthesis and Optimization Facility, with capability in preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, X-ray crystallography, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism). Applications are due May 2, 2024; January 2, 2025; May 2, 2025.
This funding opportunity from NICHD provides investigators access to the Chemical Synthesis and Optimization Facility, with capability in preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, X-ray crystallography, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism). Applications are due May 2, 2024; January 2, 2025; May 2, 2025.
-------------------------
Biological Testing Facility (X01 Clinical Trial Not Allowed)
This funding opportunity is to provide investigators with a mechanism to request services from the NICHD’s Biological Testing Facility would advance their contraceptive development program. This facility has the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, X-ray crystallography, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism). Applications are due May 2, 2024; January 2, 2025; and May 2, 2025.
This funding opportunity is to provide investigators with a mechanism to request services from the NICHD’s Biological Testing Facility would advance their contraceptive development program. This facility has the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, X-ray crystallography, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism). Applications are due May 2, 2024; January 2, 2025; and May 2, 2025.
Contraceptive Funding, Simplified